 |
|
Association of citalopram with congenital anomalies: A meta-analysis
Hyun-Hye Kang, Ki Hoon Ahn, Soon-Cheol Hong, Bo Yong Kwon, Eun Hee Lee, Ji-Sung Lee, Min-Jeong Oh, Hai-Joong Kim
Obstet Gynecol Sci. 2017;60(2):145-153. Published online 2017 Mar 16 DOI: https://doi.org/10.5468/ogs.2017.60.2.145
|
|
Citations to this article as recorded by
 Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders
Georgios Eleftheriou, Riccardo Zandonella Callegher, Raffaella Butera, Marco De Santis, Anna Franca Cavaliere, Sarah Vecchio, Alessandra Pistelli, Giovanna Mangili, Emi Bondi, Lorenzo Somaini, Mariapina Gallo, Matteo Balestrieri, Umberto Albert
International Journal of Environmental Research and Public Health.2023; 20(16): 6565. CrossRef Use of antidepressants during pregnancy and neonatal outcomes: An umbrella review of meta-analyses of observational studies
Annalisa Biffi, Anna Cantarutti, Federico Rea, Anna Locatelli, Rinaldo Zanini, Giovanni Corrao
Journal of Psychiatric Research.2020; 124: 99. CrossRef Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses
Faruk Uguz
Expert Opinion on Drug Safety.2020; 19(12): 1595. CrossRef Effect of Prenatal Citalopram Exposure on Motor and Cognitive Functions of Rats
Ayşenur ZAİMOĞLU, Bahar AKYÜZ, S. Sırrı BİLGE
Acta Medica Alanya.2019; 3(3): 213. CrossRef Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births
Shan-Yan Gao, Qi-Jun Wu, Ce Sun, Tie-Ning Zhang, Zi-Qi Shen, Cai-Xia Liu, Ting-Ting Gong, Xin Xu, Chao Ji, Dong-Hui Huang, Qing Chang, Yu-Hong Zhao
BMC Medicine.2018;[Epub] CrossRef
|